HQY

SEC source: 0001140361-17-012638 · doc1.xml · nonDerivative · entry 1

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

SEC source: 0001140361-17-010649 · doc1.xml · nonDerivative · entry 3

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 385,000

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company, on December 13, 2016.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.64, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

F4 · ownership.nature: Shares held of record by Family Holdings. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

SEC source: 0001140361-17-010648 · doc1.xml · derivative · entry 4

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,000

Underlying: Common Stock · 30,000 shares

Expires 2021-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F4 · derivative.exercise_date: The option is immediately exercisable.

SEC source: 0001140361-17-010648 · doc1.xml · nonDerivative · entry 3

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420,000

F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.55 to $44.65, inclusive.

SEC source: 0001140361-17-010648 · doc1.xml · nonDerivative · entry 2

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 421,619

F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.54 to $44.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

SEC source: 0001140361-17-010648 · doc1.xml · nonDerivative · entry 1

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

SEC source: 0001140361-17-010065 · doc1.xml · nonDerivative · entry 4

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 403,401

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company, on December 13, 2016.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.

F3 · ownership.nature: Shares held of record by Family Holdings. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

SEC source: 0001140361-17-010065 · doc1.xml · nonDerivative · entry 3

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 405,001

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company, on December 13, 2016.

F3 · ownership.nature: Shares held of record by Family Holdings. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

SEC source: 0001140361-17-008713 · doc1.xml · derivative · entry 3

MOTT DARCY G · CIK 0001179972 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 14,000 shares

Expires 2017-06-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.

F3 · derivative.exercise_date: The option is immediately exercisable.

SEC source: 0001140361-17-008713 · doc1.xml · nonDerivative · entry 2

MOTT DARCY G · CIK 0001179972 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,000

F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.40 to $42.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001140361-17-008713 · doc1.xml · nonDerivative · entry 1

MOTT DARCY G · CIK 0001179972 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.

SEC source: 0001140361-17-008096 · doc1.xml · derivative · entry 7

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 13,000 shares

Expires 2024-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

F9 · derivative.exercise_date: The option is immediately exercisable.

SEC source: 0001140361-17-008096 · doc1.xml · derivative · entry 6

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 654

Underlying: Common Stock · 33,000 shares

Expires 2021-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

F9 · derivative.exercise_date: The option is immediately exercisable.

SEC source: 0001140361-17-008096 · doc1.xml · nonDerivative · entry 5

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 405,216

F6 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company, on December 13, 2016.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.44 to $44.25, inclusive.

F8 · ownership.nature: Shares held of record by Family Holdings. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

SEC source: 0001140361-17-008096 · doc1.xml · nonDerivative · entry 4

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 847,785

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on December 13, 2016.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.49 to $44.15, inclusive.

F5 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust.

SEC source: 0001140361-17-008096 · doc1.xml · nonDerivative · entry 3

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.45 to $44.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (7) to this Form 4.

SEC source: 0001140361-17-008096 · doc1.xml · nonDerivative · entry 2

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

SEC source: 0001140361-17-008096 · doc1.xml · nonDerivative · entry 1

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

SEC source: 0001140361-17-004437 · doc1.xml · derivative · entry 6

DILLON ADRIAN T · CIK 0001163402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,837

Underlying: Common Stock · 4,837 shares

Expires 2027-02-01

F5 · derivative.exercise_date: The option becomes exercisable as to 2,418 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will become exercisable on January 31, 2018.

SEC source: 0001140361-17-004437 · doc1.xml · derivative · entry 5

DILLON ADRIAN T · CIK 0001163402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,778

Underlying: Common Stock · 1,778 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units vest as to 889 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

F4 · derivative.expiration_date: The restricted stock units vest as to 889 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

SEC source: 0001140361-17-004437 · doc1.xml · derivative · entry 4

DILLON ADRIAN T · CIK 0001163402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 647

Underlying: Common Stock · 647 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vest as to 215 shares on May 1, 2017 and in two equal installments of 216 shares on August 1, 2017 and November 1, 2017. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

F3 · derivative.expiration_date: The restricted stock units vest as to 215 shares on May 1, 2017 and in two equal installments of 216 shares on August 1, 2017 and November 1, 2017. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

SEC source: 0001140361-17-004437 · doc1.xml · nonDerivative · entry 2

DILLON ADRIAN T · CIK 0001163402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 728

SEC source: 0001140361-17-004434 · doc1.xml · derivative · entry 3

SELANDER ROBERT W · CIK 0001160228 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,556

Underlying: Common Stock · 3,556 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units will vest as to 1,778 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person on January 18, 2019, unless such date does not occur during an "open window period", in which case the shares will be delivered promptly following the first day of the next "open window period."

F3 · derivative.expiration_date: The restricted stock units will vest as to 1,778 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person on January 18, 2019, unless such date does not occur during an "open window period", in which case the shares will be delivered promptly following the first day of the next "open window period."

SEC source: 0001140361-17-004434 · doc1.xml · derivative · entry 2

SELANDER ROBERT W · CIK 0001160228 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,017

Underlying: Common Stock · 3,017 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vested as to 754 shares on February 1, 2017. The remaining restricted stock units vest in two equal installments of 754 shares on May 1, 2017 and August 1, 2017, and as to 755 shares on November 1, 2017. Vested shares will be delivered to the reporting person on January 18, 2019, unless such date does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

F2 · derivative.expiration_date: The restricted stock units vested as to 754 shares on February 1, 2017. The remaining restricted stock units vest in two equal installments of 754 shares on May 1, 2017 and August 1, 2017, and as to 755 shares on November 1, 2017. Vested shares will be delivered to the reporting person on January 18, 2019, unless such date does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

SEC source: 0001140361-17-004440 · doc1.xml · derivative · entry 4

LEAVITT MICHAEL O · CIK 0001536118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,675

Underlying: Common Stock · 9,675 shares

Expires 2027-02-01

F4 · derivative.exercise_date: The option becomes exercisable as to 4,837 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will become exercisable on January 31, 2018.

SEC source: 0001140361-17-004440 · doc1.xml · derivative · entry 3

LEAVITT MICHAEL O · CIK 0001536118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 647

Underlying: Common Stock · 647 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vest as to 215 shares on May 1, 2017 and in two equal installments of 216 shares on August 1, 2017 and November 1, 2017. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

F3 · derivative.expiration_date: The restricted stock units vest as to 215 shares on May 1, 2017 and in two equal installments of 216 shares on August 1, 2017 and November 1, 2017. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

SEC source: 0001140361-17-004440 · doc1.xml · nonDerivative · entry 1

LEAVITT MICHAEL O · CIK 0001536118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,215

SEC source: 0001140361-17-004439 · doc1.xml · derivative · entry 2

Sacks Ian · CIK 0001614866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,556

Underlying: Common Stock · 3,556 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units will vest as to 1,778 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

F2 · derivative.expiration_date: The restricted stock units will vest as to 1,778 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

SEC source: 0001140361-17-004438 · doc1.xml · derivative · entry 1

Dilsaver Evelyn S · CIK 0001391387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,556

Underlying: Common Stock · 3,556 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units will vest as to 1,778 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

F2 · derivative.expiration_date: The restricted stock units will vest as to 1,778 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

SEC source: 0001140361-17-004436 · doc1.xml · derivative · entry 2

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,675

Underlying: Common Stock · 9,675 shares

Expires 2027-02-01

F3 · derivative.exercise_date: The option becomes exercisable as to 4,837 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the option becomes exercisable as to the remaining shares on January 31, 2018.

SEC source: 0001140361-17-004436 · doc1.xml · derivative · entry 1

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 862

Underlying: Common Stock · 862 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vested as to 215 shares on February 1, 2017. The remaining restricted stock units vest as to 215 shares on May 1, 2017 and in two equal installments of 216 shares on August 1, 2017, and November 1, 2017. Vested shares will be delivered to the reporting person on February 1, 2018, unless such date does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

F2 · derivative.expiration_date: The restricted stock units vested as to 215 shares on February 1, 2017. The remaining restricted stock units vest as to 215 shares on May 1, 2017 and in two equal installments of 216 shares on August 1, 2017, and November 1, 2017. Vested shares will be delivered to the reporting person on February 1, 2018, unless such date does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

SEC source: 0001140361-17-004435 · doc1.xml · derivative · entry 1

Corvino Frank · CIK 0001614878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,556

Underlying: Common Stock · 3,556 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units will vest as to 1,778 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

F2 · derivative.expiration_date: The restricted stock units will vest as to 1,778 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person upon vesting, unless such vesting does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

SEC source: 0001140361-17-004433 · doc1.xml · derivative · entry 3

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,556

Underlying: Common Stock · 3,556 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units will vest as to 1,778 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person upon the earlier of a change of control of the issuer (as defined in the issuer's 2014 equity incentive plan), or the reporting person's termination of service (as defined in the issuer's 2014 equity incentive plan), or the reporting person's death, unless such event does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

F4 · derivative.expiration_date: The restricted stock units will vest as to 1,778 shares on the date of the issuer's annual stockholder meeting, if any, held in the current fiscal year; the remainder will vest on January 31, 2018. Vested shares will be delivered to the reporting person upon the earlier of a change of control of the issuer (as defined in the issuer's 2014 equity incentive plan), or the reporting person's termination of service (as defined in the issuer's 2014 equity incentive plan), or the reporting person's death, unless such event does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

SEC source: 0001140361-17-004433 · doc1.xml · derivative · entry 2

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,185

Underlying: Common Stock · 1,185 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units vested as to 296 shares on February 1, 2017. The remaining restricted stock units vest in two equal installments of 296 shares on May 1, 2017 and August 1, 2017, and as to 297 shares on November 1, 2017. Vested shares will be delivered to the reporting person upon the earlier of a change of control of the issuer (as defined in the issuer's 2014 equity incentive plan), or the reporting person's termination of service (as defined in the issuer's 2014 equity incentive plan), or the reporting person's death, unless such event does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

F3 · derivative.expiration_date: The restricted stock units vested as to 296 shares on February 1, 2017. The remaining restricted stock units vest in two equal installments of 296 shares on May 1, 2017 and August 1, 2017, and as to 297 shares on November 1, 2017. Vested shares will be delivered to the reporting person upon the earlier of a change of control of the issuer (as defined in the issuer's 2014 equity incentive plan), or the reporting person's termination of service (as defined in the issuer's 2014 equity incentive plan), or the reporting person's death, unless such event does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."

SEC source: 0001140361-17-004326 · doc1.xml · derivative · entry 3

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,000

Underlying: Common Stock · 30,000 shares

Expires 2021-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F3 · derivative.exercise_date: The option is immediately exercisable.

SEC source: 0001140361-17-004326 · doc1.xml · nonDerivative · entry 2

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420,000

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.05 to $46.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001140361-17-004326 · doc1.xml · nonDerivative · entry 1

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

SEC source: 0001140361-17-002755 · doc1.xml · derivative · entry 4

MOTT DARCY G · CIK 0001179972 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 14,000 shares

Expires 2017-06-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.

F4 · derivative.exercise_date: The option is immediately exercisable.

SEC source: 0001140361-17-002755 · doc1.xml · nonDerivative · entry 3

MOTT DARCY G · CIK 0001179972 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.13, inclusive.

SEC source: 0001140361-17-002755 · doc1.xml · nonDerivative · entry 2

MOTT DARCY G · CIK 0001179972 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,388

F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

SEC source: 0001140361-17-002755 · doc1.xml · nonDerivative · entry 1

MOTT DARCY G · CIK 0001179972 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.

SEC source: 0001140361-17-002558 · doc1.xml · nonDerivative · entry 1

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,763,266

F1 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

SEC source: 0001140361-17-002559 · doc1.xml · nonDerivative · entry 1

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,763,266

F1 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

SEC source: 0001140361-17-000843 · doc1.xml · derivative · entry 8

Corvino Frank · CIK 0001614878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2025-03-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is immediately exercisable.

SEC source: 0001140361-17-000843 · doc1.xml · derivative · entry 7

Corvino Frank · CIK 0001614878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2024-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option became exercisable as to 6,250 shares on June 30, 2015 and as to 6,250 on June 30, 2016. The option becomes exercisable as to the remaining 12,500 shares in two equal installments of 6,250 shares on June 30, 2017 and 2018.

SEC source: 0001140361-17-000843 · doc1.xml · derivative · entry 6

Corvino Frank · CIK 0001614878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2024-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is immediately exercisable.

SEC source: 0001140361-17-000843 · doc1.xml · nonDerivative · entry 5

Corvino Frank · CIK 0001614878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.99 to $41.07, inclusive.

SEC source: 0001140361-17-000843 · doc1.xml · nonDerivative · entry 4

Corvino Frank · CIK 0001614878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,600

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.98 to $40.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

SEC source: 0001140361-17-000843 · doc1.xml · nonDerivative · entry 3

Corvino Frank · CIK 0001614878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-17-000843 · doc1.xml · nonDerivative · entry 2

Corvino Frank · CIK 0001614878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.